Copayment Assistance Now Available to At-Risk and Infected Patients
GERMANTOWN, Md. — October 12, 2016 — The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, today announced that it opened a new fund to provide assistance to patients who are at-risk of, or infected with, potentially life-threatening fungal infections, specifically Aspergillosis and Candidiasis. Through the fund, HealthWell will provide up to $3,000 in copayment assistance to eligible patients who are insured and have annual household incomes up to 400% of the federal poverty level.
According to the Centers for Disease Control and Prevention, anyone can get a fungal infection. Fungi are common in the environment, but they are more likely to cause infections in individuals with weak immune systems, such as anyone who has cancer, has had a stem cell or organ transplant, is taking a medication that weakens the immune system, or is hospitalized for an illness that weakened the immune system. Invasive fungal infections can affect the blood, heart, brain, eyes, bones, and other parts of the body.
Aspergillosis funding: https://www.healthwellfoundation.org/fund/fungal-infections-aspergillosis-and-candidiasis/
“Candida and aspergillus infections can spread from the gut or lungs through the bloodstream with serious ramifications,” said Dr. David Denning, President, Global Action Fund for Fungal Infections (GAFFI) and Former Director of the UK’s National Aspergillosis Centre, University Hospital of South Manchester. “In the more serious hospital cases, only half the patients survive, even with therapy, and all die without antifungal treatment. Long-term antifungal therapy is costly and required for many chronic conditions. Contributions to effective and affordable treatment and prevention will often be lifesaving.”
“Thanks to the continued generosity of our donors, we are now able to offer financial relief to patients living with invasive fungal infections as well as patients who may be at-risk of infection due to compromised immune systems,” said Krista Zodet, HealthWell Foundation President.“These patients, whether they are battling an active infection or require preventative medication, desperately need treatment. Our fund offers instant grant approvals and instant pharmacy card activation to provide these patients with immediate access to care and to potentially lifesaving medications.”
Submitted by GAtherton on Thu, 2016-10-13 15:25
Share this post
Latest News posts
Aspergillosis Weekly Support Meeting
February 15, 2021
An aspergillosis diagnostic journey
February 5, 2021
Aspergillosis Monthly Patient & Carer Meeting
February 5, 2021
World Aspergillosis Day 2021
February 2, 2021
World Aspergillosis Day, 1 February 2021
January 28, 2021
COVID Vaccine for Aspergillosis Patients
December 11, 2020
COVID Precautions for the extremely vulnerable: Winter 2020
November 23, 2020
NHS: COVID-19. What if I’ve already got respiratory condition?
November 13, 2020
British Medical Journal Patient Leaflets
October 21, 2020
Vitamin D and COVID-19
October 16, 2020
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video